ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9097
0.02%
Brent Oil
82.30
-0.68%
Bitcoin
62,451.28
0.19%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ista Pharmaceuticals, Inc. (MM) (ISTA)

  7. Ista Pharmaceuticals, Inc. (MM) (ISTA) Noticias

ISTA

Ista Pharmaceuticals, Inc. (MM) (ISTA)

Ista Pharmaceuticals, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ISTA
FechaHoraFuenteTítuloSímboloCompañía
06/06/201215:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
06/06/201214:20Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
06/06/201214:10Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
06/06/201213:58Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
06/06/201208:09Edgar (US Regulatory)(25-NSE)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
05/06/201213:25MarketwiredISTA Pharmaceuticals Stockholders Vote to Approve Acquisition by Bausch + LombNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
05/06/201211:58Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
24/05/201216:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
23/05/201218:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
10/05/201210:15MarketwiredISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (...NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
04/05/201215:59Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
04/05/201205:10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
03/05/201215:01MarketwiredISTA Pharmaceuticals Reports First Quarter 2012 Financial ResultsNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
01/05/201206:30MarketwiredISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for the Tr...NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
27/04/201214:07Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
27/04/201212:46Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
24/04/201209:56Dow Jones NewsApplications Given Early Antitrust ClearanceNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
24/04/201208:38Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
23/04/201215:30MarketwiredBausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting PeriodNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
23/04/201215:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
23/04/201206:30MarketwiredISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 American Society of Cataract and Refractive Surgery (A...NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
19/04/201211:45ZacksValeant Continues Acquisition Spree - Analyst BlogNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
17/04/201215:41Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
13/04/201210:28ZacksValeant in Expansion Mode - Analyst BlogNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
02/04/201216:37PR Newswire (US)Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc.NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
02/04/201209:05Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
28/03/201219:01PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA P...NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
28/03/201212:51Business WireLaw Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc.NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
28/03/201211:19Business WireLaw Firm Brower Piven Announces Investigation in Connection With the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + LombNASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
27/03/201218:00Business WireGlancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc.NASDAQ:ISTAIsta Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ISTA

Su Consulta Reciente

NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados